Clinical Trial

Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. IV Dexmedetomidine Improves LMA Insertion Success and Decreases Coughing, While IV Lidocaine Decreases Postoperative Cough.

Study acronym: DEX LMA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 12, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-01 -> 2026-08-01 2026-05-13
minor Completion pushed: 2026-08-30 -> 2026-09-30 2026-05-13
Trial Details
NCT Number NCT07562308
Lead Sponsor Assiut University
Conditions Pediatric, Elective, Surgery in Early Childhood
Enrollment 60 participants
Start Date 2026-05-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12